Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of escitalopram and citalopram on depression in chronic kidney failure patients undergoing hemodialysis
IRCT20200304046698N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of escitalopram and citalopram in major depressive disorder (MDD) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Change in depression severity. Started Feb 2019; status: completed.
02
Drugs
escitalopramcitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20200304046698N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200304046698N1.